OXiGENE (OXGN) Offers Results Showing Median, One-Year Survival Improvement in Thyroid Cancer Patients Using ZYBRESTAT and Chemo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. SPCX
7. BABA
8. AVGO
9. HD
10. BJ

Go back to OXiGENE (OXGN) Offers Results Showing Median, One-Year Survival Improvement in Thyroid Cancer Patients Using ZYBRESTAT and Chemo
OXIGENE (NASDAQ: OXGN) Delayed: 0.70 --0 (-0%)
Previous Close $0.70    52 Week High $1.53 
Open $12.95    52 Week Low $0.49 
Day High $0.70    P/E N/A 
Day Low $0.70    EPS $-4.47 
Volume 122,547